Europe’s Advent Life Sciences has sealed a sale of KaNDy Therapeutics Ltd to industry giant Bayer in a deal which could see it collect in excess of $975m.
Europe’s Advent Life Sciences has sealed a sale of KaNDy Therapeutics Ltd to industry giant Bayer in a deal which could see it collect in excess of $975m.